Literature DB >> 25977539

Cancer immunotherapy. Neo approaches to cancer vaccines.

Lélia Delamarre1, Ira Mellman2, Mahesh Yadav1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25977539     DOI： 10.1126/science.aab3465

Source DB:  PubMed          Journal:  Science        ISSN： 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  23 in total

1.  Dendritic cell vaccination in melanoma patients: From promising results to future perspectives.

Authors:  Steve Boudewijns; Martine Bloemendal; Winald R Gerritsen; I Jolanda M de Vries; Gerty Schreibelt
Journal:  Hum Vaccin Immunother       Date:  2016-06-20       Impact factor: 3.452

2.  A novel dendritic cell targeting HPV16 E7 synthetic vaccine in combination with PD-L1 blockade elicits therapeutic antitumor immunity in mice.

Authors:  Zhida Liu; Hang Zhou; Wenjun Wang; Yang-Xin Fu; Mingzhao Zhu
Journal:  Oncoimmunology       Date:  2016-03-10       Impact factor: 8.110

Review 3.  Trial watch: Immunogenic cell death induction by anticancer chemotherapeutics.

Authors:  Abhishek D Garg; Sanket More; Nicole Rufo; Odeta Mece; Maria Livia Sassano; Patrizia Agostinis; Laurence Zitvogel; Guido Kroemer; Lorenzo Galluzzi
Journal:  Oncoimmunology       Date:  2017-10-04       Impact factor: 8.110

4.  Co-delivery of tumor antigen and dual toll-like receptor ligands into dendritic cell by silicon microparticle enables efficient immunotherapy against melanoma.

Authors:  Motao Zhu; Xilai Ding; Ruifang Zhao; Xuewu Liu; Haifa Shen; Chunmei Cai; Mauro Ferrari; Helen Y Wang; Rong-Fu Wang
Journal:  J Control Release       Date:  2018-01-08       Impact factor: 9.776

5.  Immunosurveillance of cancer and the heat shock protein-CD91 pathway.

Authors:  Robert J Binder
Journal:  Cell Immunol       Date:  2018-05-16       Impact factor: 4.868

6.  A Protease Activatable Interleukin-2 Fusion Protein Engenders Antitumor Immune Responses by Interferon Gamma-Dependent and Interferon Gamma-Independent Mechanisms.

Authors:  Karli Norville; Denise Skrombolas; Shannon L Ferry; Nolan Kearns; John G Frelinger
Journal:  J Interferon Cytokine Res       Date:  2022-07       Impact factor: 3.657

7.  Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer.

Authors:  Ugur Sahin; Evelyna Derhovanessian; Matthias Miller; Björn-Philipp Kloke; Petra Simon; Martin Löwer; Valesca Bukur; Arbel D Tadmor; Ulrich Luxemburger; Barbara Schrörs; Tana Omokoko; Mathias Vormehr; Christian Albrecht; Anna Paruzynski; Andreas N Kuhn; Janina Buck; Sandra Heesch; Katharina H Schreeb; Felicitas Müller; Inga Ortseifer; Isabel Vogler; Eva Godehardt; Sebastian Attig; Richard Rae; Andrea Breitkreuz; Claudia Tolliver; Martin Suchan; Goran Martic; Alexander Hohberger; Patrick Sorn; Jan Diekmann; Janko Ciesla; Olga Waksmann; Alexandra-Kemmer Brück; Meike Witt; Martina Zillgen; Andree Rothermel; Barbara Kasemann; David Langer; Stefanie Bolte; Mustafa Diken; Sebastian Kreiter; Romina Nemecek; Christoffer Gebhardt; Stephan Grabbe; Christoph Höller; Jochen Utikal; Christoph Huber; Carmen Loquai; Özlem Türeci
Journal:  Nature       Date:  2017-07-05       Impact factor: 49.962

8.  CD91 on dendritic cells governs immunosurveillance of nascent, emerging tumors.

Authors:  Abigail L Sedlacek; Theodore P Younker; Yu Jerry Zhou; Lisa Borghesi; Tatiana Shcheglova; Ion I Mandoiu; Robert J Binder
Journal:  JCI Insight       Date:  2019-04-04

9.  Adjuvant-free peptide vaccine targeting Clec9a on dendritic cells can induce robust antitumor immune response through Syk/IL-21 axis.

Authors:  Shanshan Gou; Shuai Wang; Wenwen Liu; Guanyu Chen; Dongyang Zhang; Jiangfeng Du; Zhongyi Yan; Hongfei Wang; Wenjie Zhai; Xinghua Sui; Yahong Wu; Yuanming Qi; Yanfeng Gao
Journal:  Theranostics       Date:  2021-05-24       Impact factor: 11.556

Review 10.  Genetic instability in the tumor microenvironment: a new look at an old neighbor.

Authors:  Antonio Palumbo; Nathalia de Oliveira Meireles Da Costa; Martin Hernan Bonamino; Luis Felipe Ribeiro Pinto; Luiz Eurico Nasciutti
Journal:  Mol Cancer       Date:  2015-07-31       Impact factor: 27.401
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.